Aptose Biosciences
APTO
#10460
Rank
ยฃ3.25 M
Marketcap
ยฃ1.28
Share price
0.00%
Change (1 day)
752.07%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -ยฃ16.16 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ18.84 Million, an increase over its 2023 earnings that were of -ยฃ39.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ16.16 Million-14.22%
2024 -ยฃ18.84 Million-51.82%
2023 -ยฃ39.1 Million22.9%
2022 -ยฃ31.82 Million-34.91%
2021 -ยฃ48.88 Million17.36%
2020 -ยฃ41.65 Million107.65%
2019 -ยฃ20.06 Million-7.73%
2018 -ยฃ21.74 Million160.68%
2017 -ยฃ8.34 Million-20.27%
2016 -ยฃ10.46 Million28.71%
2015 -ยฃ8.13 Million
2013 -ยฃ4.61 Million
2010 -ยฃ3.93 Million-8.31%
2009 -ยฃ4.28 Million
2006 -ยฃ7.94 Million-156.93%
2005 ยฃ13.93 M-185.16%
2004 -ยฃ16.37 Million458.58%
2003 -ยฃ2.93 Million-63.66%
2002 -ยฃ8.07 Million-8.04%
2001 -ยฃ8.77 Million16.73%
2000 -ยฃ7.51 Million294.99%
1999 -ยฃ1.91 Million-6.51%
1998 -ยฃ2.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-ยฃ25.41 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-ยฃ43 Million 175.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-ยฃ46.89 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA